- Thinly traded Twist Biosciences (NASDAQ:TWST +7.3%) is up on more than triple normal volume, turnover of 988K shares, in reaction to its announcement that it has been selected as a subcontractor to Georgia Tech Research Institute in a contract with the Office of the Director of National Intelligence's Intelligence Advanced Research Projects Activity (IARPA).
- The company will be responsible for the DNA synthesis portion of the Molecular Information Storage program which is aimed at making long-term DNA data storage accessible and commercially viable within the next three-to-five years.
- Twist's DNA synthesis platform enables it to manufacture synthetic DNA by "writing" it on a silicon chip.